CosmosID, a microbiome analytics company with a genomic sequencing facility in Germantown, Thursday announced a collaboration with Resilient Biotics to explore the microbiome strains that colonize the respiratory tract tissues, a step toward advancing respiratory health research and therapeutic development. CosmosID will offer a range of next-generation sequencing services and advanced bioinformatic support.
CosmosID, Resilient Biotics collaborate to advance respiratory health research
March 27, 2024
